OCT 14, 2020 7:30 AM PDT

Self-Healing Microcapsules Make Promising Leukemia Vaccines

WRITTEN BY: Tara Fernandez

Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic system.  It is characterized by rapid, out-of-control growth of abnormal cells in these tissues and accounts for around four percent of all new cancer cases in the United States.

A recent study published in Nature Biomedical Engineering details how researchers are a step closer towards a therapeutic vaccine against leukemia. Though previous works have shown promise in preventing the development of leukemia through vaccination, the clinical performance of such experimental therapies has been underwhelming so far. In part, this is due to shortcomings of the vaccine’s delivery system.

Professor Li Yuhua, from China’s Zhujiang Hospital was among the scientists leading the study and said: "Our clinical findings revealed the high expression of EPS8 and PD-1/PD-L1 in leukemia patients, which could be respectively used as a new type of leukemia antigen and a checkpoint target for a leukemia vaccine."

The team designed a novel self-healing microcapsule that contains a cargo of epitope peptides and an antibody against PD-1. These microcapsules are made of polylactic acid, an FDA-approved biomaterial that is regarded as a reference material for injectable microparticles. What’s special about these newly-developed microcapsules is their ability to efficiently load the vaccine’s active ingredients and subsequently “self heal”, sealing them in before releasing the vaccine over a prolonged period once injected into the body.

The microcapsules performed considerably better than currently-available adjuvants in a variety of leukemia therapeutic models, highlighting their exciting potential in a clinical setting.

"With the advantages of FDA-approved polylactic acid material, convenience in preparing the vaccine formulation, diversity of vaccine components, and excellent therapeutic effect, the microcapsule-based vaccine exhibits great potential for clinical translation," said Professor Ma Guanghui from the Institute of Process Engineering (IPE) of Chinese Academy of Sciences, another author of the paper.

Sources: Nature Biomedical Engineering, Medical Xpress.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 28, 2020
Cell & Molecular Biology
How B Cells Find Their Way to Lymph Nodes
JUL 28, 2020
How B Cells Find Their Way to Lymph Nodes
In order to generate immunity against invaders, some immune cells have to get to the lymph nodes. So how do they know ho ...
AUG 04, 2020
Microbiology
Why the Brain Parasite You May Carry Isn't a Problem
AUG 04, 2020
Why the Brain Parasite You May Carry Isn't a Problem
Toxoplasma gondii is a parasite transmitted by cats and contaminated meat, and it's thought that over 30 million America ...
AUG 06, 2020
Immunology
Resetting the Body's Danger Sensor
AUG 06, 2020
Resetting the Body's Danger Sensor
The human body has a sophisticated danger-sensing mechanism that alerts the immune system when something is not right. T ...
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 01, 2020
Immunology
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
SEP 01, 2020
Cell Atlas of Mosquito Immunology Reveals New Avenues for Eradicating Malaria
Malaria is one of the biggest ongoing threats to global health — over 200 million were infected and almost half a ...
SEP 02, 2020
Immunology
Alarmins: The Immune "Gold" in Breast Milk
SEP 02, 2020
Alarmins: The Immune "Gold" in Breast Milk
We know that infants fed with breast milk develop more robust immune systems as a result of factors that support the nat ...
Loading Comments...